Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASSEMBLY BIOSCIENCES, INC. Director's Dealing 2025

Apr 1, 2025

33081_dirs_2025-04-01_ad1bb349-e6e3-420e-be7b-779b353f6bea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK: 0001426800
Period of Report: 2025-03-29

Reporting Person: Gaggar Anuj (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-03-29 Stock Option (right to buy) $10.62 A 24200 Acquired 2035-03-29 Common Stock (24200) Direct

Footnotes

F1: Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2026; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2029.